C07D 409 - Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms

Patents for C07D 409 - Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms (52,226)
11/2009
11/12/2009	WO2009137782A2 Allosteric enhancers of the a1 adenosine receptor
11/12/2009	WO2009137596A1 Substituted amides, method of making, and use as btk inhibitors
11/12/2009	WO2009137544A1 Therapeutic substituted thiazolidinones, oxazolidinones, and related compounds
11/12/2009	WO2009137538A2 Fungicidal substituted azoles
11/12/2009	WO2009137412A1 Therapeutic compounds
11/12/2009	WO2009137404A1 Urea compounds as gamma secretase modulators
11/12/2009	WO2009137343A1 Therapeutic substituted hydantoins, and related compounds
11/12/2009	WO2009137339A2 Therapeutic n-aryl or n-heteroaryl pyrazolidine and pyrazolidinone derivatives
11/12/2009	WO2009137081A2 Small molecule inhibitors of plasmodium falciparum dihydroorotate dehydrogenase
11/12/2009	WO2009136995A2 Inhibitors of syk protein kinase
11/12/2009	WO2008133344A3 Piperidine derivative and use thereof
11/12/2009	WO2007084435A8 Methods for treating hepatitis c
11/12/2009	US20090281336 Benzofuran compounds, compositions and methods for treatment and prophylaxis of hepatitis c viral infections and associated diseases
11/12/2009	US20090281317 3-ethylidenehydrazino substituted heterocyclic compounds as thrombopoietin receptor activators
11/12/2009	US20090281310 Cinnamide compound
11/12/2009	US20090281308 Chemokine receptor binding heterocyclic compounds with enhanced efficacy
11/12/2009	US20090281171 Therapeutic substituted thiazolidinones, oxazolidinones, and related compounds
11/12/2009	US20090281145 Allosteric enhancers of the a1 adenosine receptor
11/12/2009	US20090281137 Indol-2-one derivatives for the treatment of central nervous disorders, gastrointestinal disorders and cardiovascular disorders
11/12/2009	US20090281102 Therapeutic n-aryl or n-heteroaryl pyrazolidine and pyrazolidinone derivatives
11/12/2009	US20090281101 5-(3-(3-(4-hexanoylphenyl)-2,5-dioxoimidazolidin-4-yl)propyl)thiophene-2-carboxylic acid; prostaglandin agonist; ocular hypotensive agent; post-sergical and post-laser trabeculectomy ocular hypertensive episodes, glaucoma, and as presurgical adjuncts
11/12/2009	US20090281100 Benzimidazole quinolinones and uses thereof
11/12/2009	US20090281097 Nitrogen-containing heterocyclic compound
11/12/2009	US20090281086 2 -oxyheteroarylamide derivatives as parp inhibitors
11/12/2009	US20090281081 Chemokine receptor antagonists and methods of use therefor
11/12/2009	US20090281072 Diaminopyrimidinecarboxamide Derivative
11/12/2009	CA2728893A1 Inhibitors of syk protein kinase
11/12/2009	CA2728229A1 Therapeutic substituted thiazolidinones, oxazolidinones, and related compounds
11/12/2009	CA2723894A1 Therapeutic substituted hydantoins, and related compounds
11/12/2009	CA2723893A1 Therapeutic n-aryl or n-heteroaryl pyrazolidine and pyrazolidinone derivatives
11/12/2009	CA2723237A1 Substituted amides, method of making, and use as btk inhibitors
11/12/2009	CA2723146A1 Allosteric enhancers of the a1 adenosine receptor
11/12/2009	CA2722606A1 Urea compounds as gamma secretase modulators
11/11/2009	EP2116538A1 Condensed tetrahydroquinoline derivative and use thereof for medical purposes
11/11/2009	EP2116530A1 Novel pyrrole derivative having ureide group and aminocarbonyl group as substituents
11/11/2009	EP2114920A1 Substituted isoquinoline and isoquinolinone derivatives
11/11/2009	EP2114917A2 Pyrrole compounds
11/11/2009	EP2114902A2 Hiv inhibiting 5,6-substituted pyrimidines
11/11/2009	EP2114901A1 Hiv inhibiting 6-substituted pyrimidines
11/11/2009	EP1917246B1 Benzoquinazoline derivatives and their use in treating bone disorders
11/11/2009	EP1833816B1 Substituted piperidines as renin inhibitors
11/11/2009	EP1756193B1 Monomer, oligomer and pi-conjugated polymer compounds, and photovoltaic cells containing same
11/11/2009	EP1713823B1 Hcv ns-3 serine protease inhibitors
11/11/2009	EP1709023B1 Selective estrogen receptor modulators
11/11/2009	EP1668002B1 2,4-dioxo-3-quinazolinylaryl sulfonylureas
11/11/2009	EP1606255B1 Cyclic derivatives as modulators of chemokine receptor activity
11/11/2009	EP1255726B1 (r)-2-aryl-propionamides, useful in the inhibition of il-8 induced chemiotaxis of neutrophils
11/11/2009	CN101578278A Substituted 1-(azolin-2-yl)-amino-1,2-heterocyclyl-ethane compounds for combating pests
11/11/2009	CN101578277A 5-substituted isoindoline compounds
11/11/2009	CN101578273A Hydroxylated and methoxylated cyclopenta [d] pyrimidines as akt protein kinase inhibitors
11/11/2009	CN101578265A Sulfonamide derivatives as chymase inhibitors
11/11/2009	CN101578261A Heteroaryl-substituted serine amides
11/11/2009	CN101575314A Dihydropyridine compounds and application thereof on preparing drugs for curing and/or preventing virus diseases
11/11/2009	CN100558728C Calcitonin gene related peptide receptor antagonists
11/11/2009	CN100558725C Quinazoline derivatives as antiproliferative agents
11/11/2009	CN100558724C Sulphonic acid amide for regulating bast peptide activity and derivative thereof
11/11/2009	CN100558713C Pyridazine derivatives and their use as therapeutic agents
11/11/2009	CN100558701C N-(2-phenylethyl)sulfamide derivatives as integrin alpha4 antagonists
11/11/2009	CN100558697C Cycloalkyl inhibitors of potassium channel function
11/11/2009	CN100558355C Indol-5 sulfonamide derivatives, their preparation and their use 5-ht-6 as modulators
11/10/2009	US7615643 Benzimidazole thiophene compounds
11/10/2009	US7615634 intermediate for synthesis an enzyme inhibitor of cyclin-dependent kinases, having antiproliferative activity and are useful in the treatment or control of cancer, in particular solid tumors
11/10/2009	US7615564 Such as N5-[1-(2-chlorobenzyl)tetrahydro-1H-3-pyrrolyl]-5-isoquinolylamine; Rho kinase inhibitors; hypertension, asthma, angina pectoris, cerebrovascular contraction, peripheral circulatory disorder, threatened premature birth, glaucoma, vision disorders, autoimmune diseases, chronic renal failure
11/10/2009	US7615563 Compositions useful as inhibitors of voltage-gated sodium channels
11/10/2009	US7615562 Such as 2-methyl-4-{5-[2-(2,2,6,6-tetramethyl-piperidin-4-ylamino)-pyrimidin-4-yl]-thiophen-2-yl}-butan-2-ol; tumor necrosis factor inhibitors; immunosuppressants; antiinflammatory agents
11/10/2009	US7615553 E.g., N,N-dimethyl,((5-(hydroxyaminocarbonyl)pyrimidin-2-yl)(piperazin-1,4-ylene)sulfonamide; bioavailability; oral administration; metabolic stability; side effect reduction; psoriasis; anticarcinogenic -proliferative, -arthritic, -inflammatory agent; gene therapy; genetic transcription potentiation
11/10/2009	US7615552 Fused heterocyclic compounds
11/10/2009	US7615208 Administering a radionuclide-labeled bis-aminoethanethiol (BAT) tetradentate targeting ligand conjugate, which is a folate receptor targeting ligand, an agent that mimics glucose, annexin V, colchicine, glutamate pentapeptide, or a tumor hypoxia targeting ligand
11/10/2009	CA2417401C Benzofuran derivatives and their use as antibacterial agents
11/10/2009	CA2416785C Novel arylethene-sulfonamides
11/10/2009	CA2401637C N-(heterocyclyl)benzene- or - pyridinesulphonamides as antithrombotic and anticoagulant agents
11/10/2009	CA2353460C Carboxylic acids and carboxylic acid isosteres of n-heterocyclic compounds
11/05/2009	WO2009134741A1 Dual-acting antihypertensive agents
11/05/2009	WO2009133964A1 Agent for prevention of oxidative stress
11/05/2009	WO2009133861A1 Cyclic amine compound
11/05/2009	WO2009133389A1 Methods of preparing substituted heterocycles
11/05/2009	WO2009133348A1 Aminopyridine derivatives
11/05/2009	WO2009091898A3 6-and 7-amino isoquinoline compounds and methods for making and using the same
11/05/2009	WO2009013122A3 Azo dyes
11/05/2009	WO2004013122A3 Octupolar molecules used as organic semi-conductors
11/05/2009	US20090275751 1,2-dihydropyridine compounds, manufacturing method thereof and use thereof
11/05/2009	US20090275572 Fab i inhibitors
11/05/2009	US20090275565 Substituted aralkyl derivatives
11/05/2009	US20090275550 2-(4-isopropenylphenyl)-N-[(1R)-1-(5-(2,2,2-trifluoroethoxy)pyridin-2-yl)ethyl]acetamide; epilepsy, pain, neuropathic pain, schizophrenia, Parkinson's disease, depression, anxiety, sleep disorders, psychosis, schizophrenia, cardiac arrhythmia and hypertension
11/05/2009	US20090275535 Antiviral phosphonate analogs
11/05/2009	US20090275515 2-hydroxy-2-phenylthiophenylpropionamides as androgen receptor modulators
11/05/2009	US20090274655 2-carboxy thiophene derivatives as anti viral agents
11/05/2009	CA2722648A1 Aminopyridine derivatives
11/05/2009	CA2722577A1 4-oxo-1,4-dihydroquinoline m1 receptor positive allosteric modulators
11/05/2009	CA2722339A1 Methods of preparing substituted heterocycles - 149
11/04/2009	EP1979345B1 Novel pyridine derivatives
11/04/2009	EP1641465B1 Combinations of an aryl aniline beta-2 adrenergic receptor agonist and a corticosteroid
11/04/2009	EP1615613B1 Quinoxalinyl macrocyclic hepatitis c serine protease inhibitors
11/04/2009	EP1499311B1 Substituted benzazoles and use thereof as raf kinase inhibitors
11/04/2009	EP1446387B1 Substituted aryl 1,4-pyrazine derivatives
11/04/2009	CN101573353A Substituted isoquinoline and isoquinolinone derivatives
11/04/2009	CN101573346A Process for the synthesis of derivatives of 3-amino-tetrahydrofuran-3-carboxylic acid and use thereof as medicaments
11/04/2009	CN101573343A HIV inhibiting 6-substituted pyrimidines
11/03/2009	US7612201 Pyrazole compounds
11/03/2009	US7612094 Tri-substituted heteroaryls and methods of making and using the same

1 ... 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 ... 523